These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 24904430)
1. Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects. Chistiakov DA; Sobenin IA; Orekhov AN; Bobryshev YV Front Physiol; 2014; 5():196. PubMed ID: 24904430 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis. Takeda M; Yamashita T; Sasaki N; Hirata K J Atheroscler Thromb; 2012; 19(11):953-61. PubMed ID: 22878702 [TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response. Chistiakov DA; Sobenin IA; Orekhov AN Immunol Lett; 2013 Mar; 151(1-2):10-22. PubMed ID: 23411158 [TBL] [Abstract][Full Text] [Related]
4. Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation. Chistiakov DA; Sobenin IA; Orekhov AN; Bobryshev YV Immunobiology; 2015 Jun; 220(6):833-44. PubMed ID: 25595536 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells: a double-edge sword in atherosclerotic inflammation. Chistiakov DA; Sobenin IA; Orekhov AN; Bobryshev YV Curr Pharm Des; 2015; 21(9):1118-23. PubMed ID: 25312726 [TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Chistiakov DA; Orekhov AN; Sobenin IA; Bobryshev YV Front Physiol; 2014; 5():279. PubMed ID: 25120492 [TBL] [Abstract][Full Text] [Related]
7. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. Mahnke K; Johnson TS; Ring S; Enk AH J Dermatol Sci; 2007 Jun; 46(3):159-67. PubMed ID: 17428639 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro. Pletinckx K; Lutz MB Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473 [TBL] [Abstract][Full Text] [Related]
9. Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells. Nikolic T; Roep BO Front Immunol; 2013; 4():113. PubMed ID: 23717310 [TBL] [Abstract][Full Text] [Related]
10. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Dietel B; Cicha I; Voskens CJ; Verhoeven E; Achenbach S; Garlichs CD Atherosclerosis; 2013 Sep; 230(1):92-9. PubMed ID: 23958259 [TBL] [Abstract][Full Text] [Related]
11. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. Schülke S Front Immunol; 2018; 9():455. PubMed ID: 29616018 [TBL] [Abstract][Full Text] [Related]
12. Impaired Autophagy in CD11b Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells and their role in atherogenesis. Bobryshev YV Lab Invest; 2010 Jul; 90(7):970-84. PubMed ID: 20458277 [TBL] [Abstract][Full Text] [Related]
14. Infectious tolerance as candidate therapy for type 1 diabetes: transfer of immunoregulatory properties from human regulatory T cells to other T cells and proinflammatory dendritic cells. Kleijwegt FS; Roep BO Crit Rev Immunol; 2013; 33(5):415-34. PubMed ID: 24099301 [TBL] [Abstract][Full Text] [Related]
15. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Gleisner MA; Rosemblatt M; Fierro JA; Bono MR Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264 [TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis. Sasaki N; Yamashita T; Kasahara K; Takeda M; Hirata K Curr Pharm Des; 2015; 21(9):1107-17. PubMed ID: 25312730 [TBL] [Abstract][Full Text] [Related]
17. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Bros M; Jährling F; Renzing A; Wiechmann N; Dang NA; Sutter A; Ross R; Knop J; Sudowe S; Reske-Kunz AB Blood; 2007 May; 109(9):3820-9. PubMed ID: 17209058 [TBL] [Abstract][Full Text] [Related]
18. Potential use of dendritic cells for anti-atherosclerotic therapy. Van Brussel I; Schrijvers DM; Van Vré EA; Bult H Curr Pharm Des; 2013; 19(33):5873-82. PubMed ID: 23438957 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709 [TBL] [Abstract][Full Text] [Related]
20. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. Li G; Kim YJ; Broxmeyer HE J Immunol; 2005 Apr; 174(8):4706-17. PubMed ID: 15814695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]